Keywords: Caucasian; IL-6; IL-6, interleukin 6; PG, pyoderma gangrenosum; Takayasu's arteritis; biologic agent; biologic therapy; biologics; dermatology; monoclonal antibodies; monoclonal antibody; pyoderma gangrenosum; tocilizumab; vasculitis.